Autolus Therapeutics Ownership | Who Owns Autolus Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Autolus Therapeutics Ownership Summary

Autolus Therapeutics is owned by 7.57% institutional investors, 5.56% insiders, and 86.87% retail investors. Mak capital one is the largest institutional shareholder, holding 9.78% of AUTL shares. Syncona Ord is the top mutual fund, with 11.55% of its assets in Autolus Therapeutics shares.

AUTL Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Autolus Therapeutics	7.57%	5.56%	86.87%
Sector	Healthcare Stocks	232.51%	10.72%	-143.23%
Industry	Biotech Stocks	384.56%	10.58%	-295.14%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Mak capital one	26.02M	9.78%	$42.41M
Blackstone	20.49M	7.70%	$33.39M
Syncona portfolio	16.64M	6.25%	$33.12M
Armistice capital	15.60M	5.86%	$25.43M
Tfg asset management gp	9.50M	3.57%	$15.48M
Schroder investment management group	8.43M	3.17%	$13.41B
Blackrock	4.44M	2.00%	$15.44M
Frazier life sciences management	4.62M	1.74%	$7.54M
Blackrock funding, inc. /de	3.69M	1.38%	$7.33M
Axa investment managers	3.36M	1.26%	$5.48M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Syncona portfolio	16.64M	96.48%	$33.12M
Mak capital one	26.02M	6.52%	$42.41M
Tfg asset management gp	9.50M	2.07%	$15.48M
Healthinvest partners ab	1.17M	0.74%	$2.33M
Armistice capital	15.60M	0.38%	$25.43M
Caitong asset management	44.05K	0.24%	$87.67K
Frazier life sciences management	4.62M	0.23%	$7.54M
Nano cap new millennium growth fund l p	112.50K	0.19%	$223.88M
Edentree asset management	300.00K	0.18%	$594.00K
Aubrey capital management	225.20K	0.18%	$444.97K

Top Buyers

Holder	Shares	% Assets	Change
Mak capital one	26.02M	6.52%	9.06M
Schroder investment management group	8.43M	0.01%	4.82M
Armistice capital	15.60M	0.38%	3.60M
Axa investment managers	3.36M	0.01%	3.36M
Millennium management	1.65M	0.00%	790.44K

Top Sellers

Holder	Shares	% Assets	Change
Wellington management group llp	-	-	-27.15M
Avoro capital advisors	-	-	-9.91M
Fmr	-	-	-7.11M
Cormorant asset management, lp	-	-	-6.62M
Paradigm biocapital advisors lp	-	-	-6.43M

New Positions

Holder	Shares	% Assets	Change	Value
Axa investment managers	3.36M	0.01%	3.36M	$5.48M
Arizona psprs trust	150.00K	0.01%	150.00K	$298.50K
Graham capital management	147.88K	0.00%	147.88K	$241.04K
Public employees retirement system of ohio	132.69K	0.00%	132.69K	$216.28K
Gsa capital partners llp	119.55K	0.02%	119.55K	$238.00K

Sold Out

Holder	Change
Principal securities	-37.00
Us bancorp \de\	-64.00
Cornerstone planning group	-100.00
Raymond james financial	-200.00
Carmichael hill & associates	-254.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	24	-75.76%	20,150,499	-86.07%	7	0.26%	8	-82.98%	8	-68.00%
Sep 30, 2025	32	-66.32%	22,001,645	-86.74%	8	0.21%	8	-84.31%	14	-50.00%
Jun 30, 2025	93	-2.11%	165,894,039	9.60%	62	1.93%	49	25.64%	27	-15.63%
Mar 31, 2025	95	-12.04%	168,007,060	-0.18%	63	1.58%	39	-29.09%	32	6.67%
Dec 31, 2024	105	3.96%	163,675,281	-8.36%	61	1.37%	54	50.00%	30	-16.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Syncona Ord	30.73M	11.55%	9.39M
Vanguard Health Care Inv	19.36M	7.27%	-
FIAM Small Cap Core CIT Cl B	4.02M	1.51%	946.70K
FIAM Small Cap Core Composite	3.14M	1.18%	-26.57K
Fidelity Small Cap Growth	2.57M	0.97%	-
International Biotechnology Ord	2.41M	0.90%	472.01K
AXA Framlington Health Fund - R Income	2.37M	0.89%	-751.84K
US Small-Cap Growth II Equity Comp	2.02M	0.76%	-216.32K
Wellington Global Hlthcr Eq USD G Ac	1.79M	0.67%	-
Fidelity Stock Selector Small Cap	1.62M	0.61%	-348.11K

AUTL Ownership FAQ

Who Owns Autolus Therapeutics?

Autolus Therapeutics shareholders are primarily institutional investors at 7.57%, followed by 5.56% insiders and 86.87% retail investors. The average institutional ownership in Autolus Therapeutics's industry, Biotech Stocks , is 384.56%, which Autolus Therapeutics falls below.

Who owns the most shares of Autolus Therapeutics?

Autolus Therapeutics’s largest shareholders are Mak capital one (26.02M shares, 9.78%), Blackstone (20.49M shares, 7.70%), and Syncona portfolio (16.64M shares, 6.25%). Together, they hold 23.73% of Autolus Therapeutics’s total shares outstanding.

Does Blackrock own Autolus Therapeutics?

Yes, BlackRock owns 2.00% of Autolus Therapeutics, totaling 4.44M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 15.44M$. In the last quarter, BlackRock increased its holdings by 380.18K shares, a 9.37% change.

Who is Autolus Therapeutics’s biggest shareholder by percentage of total assets invested?

Syncona portfolio is Autolus Therapeutics’s biggest shareholder by percentage of total assets invested, with 96.48% of its assets in 16.64M Autolus Therapeutics shares, valued at 33.12M$.

Who is the top mutual fund holder of Autolus Therapeutics shares?

Syncona Ord is the top mutual fund holder of Autolus Therapeutics shares, with 11.55% of its total shares outstanding invested in 30.73M Autolus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools